Different phenotypic consequences of simultaneous versus stepwise Apc loss

Oncogene

Volumn 31, Issue 16, 2012, Pages 2028-2038

  Fischer, J M ^a   Miller, A J ^a   Shibata, D ^b   Liskay, R M ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

APC; cancer; simultaneous; stepwise intestine

Indexed keywords

APC PROTEIN; BETA CATENIN; CRE RECOMBINASE;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE MUTATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEPLETION;

ALLELES; ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; COLORECTAL NEOPLASMS; GENES, APC; INTEGRASES; INTESTINE, SMALL; MICE; MUTATION; PHENOTYPE; SIGNAL TRANSDUCTION;

MUS; PYRONIA TITHONUS;

EID: 84859894474     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.385     Document Type: Article

References (35)

1. Akyol A, Hinoi T, Feng Y, Bommer GT, Glaser TM, Fearon ER. (2008). Generating somatic mosaicism with a Cre recombinase-microsatellite sequence transgene. Nat Methods 5: 231-233. (Pubitemid 351325645)
2. Attolini CS, Cheng YK, Beroukhim R, Getz G, Abdel-Wahab O, Levine RL et al. (2010). A mathematical framework to determine the temporal sequence of somatic genetic events in cancer. Proc Natl Acad Sci USA 107: 17604-17609.
3. Barker N, Ridgway RA, van Es JH, van de Wetering M, Begthel H, van den Born M et al. (2009). Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 457: 608-611.
4. Buchert M, Athineos D, Abud HE, Burke ZD, Faux MC, Samuel MS et al. (2010). Genetic dissection of differential signaling threshold requirements for the Wnt/beta-catenin pathway in vivo. PLoS Genet 6: e1000816.
5. Chan MF, van Amerongen R, Nijjar T, Cuppen E, Jones PA, Laird PW. (2001). Reduced rates of gene loss, gene silencing, and gene mutation in Dnmt1-deficient embryonic stem cells. Mol Cell Biol 21: 7587-7600. (Pubitemid 32988770)
6. Chen RZ, Pettersson U, Beard C, Jackson-Grusby L, Jaenisch R. (1998). DNA hypomethylation leads to elevated mutation rates. Nature 395: 89-93. (Pubitemid 28420236)
7. Cruz-Correa M, Hylind LM, Romans KE, Booker SV, Giardiello FM. (2002). Long-term treatment with sulindac in familial adenomatous polyposis: a prospective cohort study. Gastroenterology 122: 641-645. (Pubitemid 34173815)
8. Eads CA, Nickel AE, Laird PW. (2002). Complete genetic suppression of polyp formation and reduction of CpG-island hypermethylation in Apc(Min/+) Dnmt1-hypomorphic mice. Cancer Res 62: 1296-1299. (Pubitemid 34407781)
9. Fearon ER, Vogelstein B. (1990). A genetic model for colorectal tumorigenesis. Cell 61: 759-767.
10. Fodde R, Edelmann W, Yang K, van Leeuwen C, Carlson C, Renault B et al. (1994). A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors. Proc Natl Acad Sci USA 91: 8969-8973.
11. Forbes SA, Tang G, Bindal N, Bamford S, Dawson E, Cole C et al. (2010). COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer. Nucleic Acids Res 38: D652-D657.
12. Hung KE, Maricevich MA, Richard LG, Chen WY, Richardson MP, Kunin A et al. (2010). Development of a mouse model for sporadic and metastatic colon tumors and its use in assessing drug treatment. Proc Natl Acad Sci USA 107: 1565-1570.
13. Kinzler KW, Vogelstein B. (1996). Lessons from hereditary colorectal cancer. Cell 87: 159-170. (Pubitemid 26358996)
14. Kuraguchi M, Wang XP, Bronson RT, Rothenberg R, Ohene-Baah NY, Lund JJ et al. (2006). Adenomatous polyposis coli (APC) is required for normal development of skin and thymus. PLoS Genet 2: e146.
15. Laird PW, Jackson-Grusby L, Fazeli A, Dickinson SL, Jung WE, Li E et al. (1995). Suppression of intestinal neoplasia by DNA hypomethylation. Cell 81: 197-205.
16. Lopez-Garcia C, Klein AM, Simons BD, Winton DJ. (2010). Intestinal stem cell replacement follows a pattern of neutral drift. Science 330: 822-825.
17. Lynch PM. (2010). Pharmacotherapy for inherited colorectal cancer. Expert Opin Pharmacother 11: 1101-1108.
18. Miller AJ, Dudley SD, Tsao JL, Shibata D, Liskay RM. (2008). Tractable Cre-lox system for stochastic alteration of genes in mice. Nat Methods 5: 227-229. (Pubitemid 351325644)
19. Moser AR, Pitot HC, Dove WF. (1990). A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247: 322-324.
20. Oshima M, Oshima H, Kitagawa K, Kobayashi M, Itakura C, Taketo M. (1995). Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene. Proc Natl Acad Sci USA 92: 4482-4486.
21. Patel BB, Li XM, Dixon MP, Blagoi EL, Nicolas E, Seeholzer SH et al. (2011). APC+/- alters colonic fibroblast proteome in FAP. Oncotarget 2: 197-208.
22. Pleasance ED, Cheetham RK, Stephens PJ,McBride DJ, Humphray SJ, Greenman CD et al. (2010). A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 463: 191-196.
23. Quante M, Tu SP, Tomita H, Gonda T, Wang SS, Takashi S et al. (2011). Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth. Cancer Cell 19: 257-272.
24. Quintana E, Shackleton M, Foster HR, Fullen DR, Sabel MS, Johnson TM et al. (2010). Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized. Cancer Cell 18: 510-523.
25. Quyn AJ, Appleton PL, Carey FA, Steele RJ, Barker N, Clevers H et al. (2010). Spindle orientation bias in gut epithelial stem cell compartments is lost in precancerous tissue. Cell Stem Cell 6: 175-181.
26. Sansom OJ, Reed KR, Hayes AJ, Ireland H, Brinkmann H, Newton IP et al. (2004). Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration. Genes Dev 18: 1385-1390. (Pubitemid 38780625)
27. Sasai H, Masaki M, Wakitani K. (2000). Suppression of polypogenesis in a new mouse strain with a truncated Apc(Delta474) by a novel COX-2 inhibitor, JTE-522. Carcinogenesis 21: 953-958. (Pubitemid 30265139)
28. Shibata H, Toyama K, Shioya H, Ito M, Hirota M, Hasegawa S et al. (1997). Rapid colorectal adenoma formation initiated by conditional targeting of the Apc gene. Science 278: 120-123.
29. Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD et al. (2006). The consensus coding sequences of human breast and colorectal cancers. Science 314: 268-274. (Pubitemid 44571966)
30. Smits R, van der Houven van Oordt W, Luz A, Zurcher C, Jagmohan-Changur S, Breukel C et al. (1998). Apc1638N: a mouse model for familial adenomatous polyposis-associated desmoid tumors and cutaneous cysts. Gastroenterology 114: 275-283. (Pubitemid 28093534)
31. Snippert HJ, van der Flier LG, Sato T, van Es JH, van den Born M, Kroon-Veenboer C et al. (2010). Intestinal crypt homeostasis results from neutral competition between symmetrically dividing Lgr5 stem cells. Cell 143: 134-144.
32. Su LK, Kinzler KW, Vogelstein B, Preisinger AC, Moser AR, Luongo C et al. (1992). Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 256: 668-670.
33. Vermeulen L, De Sousa EMF, van der Heijden M, Cameron K, de Jong JH, Borovski T et al. (2010). Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat Cell Biol 12: 468-476.
34. Wang D, Pezo RC, Corner G, Sison C, Lesser ML, Shenoy SM et al. (2010). Altered dynamics of intestinal cell maturation in Apc1638N/+ mice. Cancer Res 70: 5348-5357.
35. Yeung AT, Patel BB, Li X-M, Seeholzer SH, Coudry RA, Cooper HS et al. (2008). One-hit effects in cancer: altered proteome of morphologically normal colon crypts in familial adenomatous polyposis. Cancer Res 68: 7579-7586.